2023-02-09: A Review of Women’s Health and Preventative Medicine
1. Describe pharmacologic properties and considerations of various forms of contraception .
2. Identify key recommendations and updates for contraception, emergency contraception, and abortive therapy.
3. Evaluate the use of various forms of contraception in specific patient cases and scenarios.
4. Describe the epidemiology and pathophysiology of osteoporosis.
5. Identify appropriate medical management strategies and medications for the treatment of osteoporosis .
6. Discuss various side effect profiles and considerations for the medications used in the treatment of osteoporosis.
7. Identify updated USPTF preventative screening recommendations pertinent to pharmacy practice.
8. Discuss strategies for pharmacist driven implementation of preventative screening measures.
9. Recognize updates in pregnancy and lactation categories for medications.
10. Discuss specific patient considerations related to updated pregnancy and lactation considerations .
Course Fee: $119
Therapeutic Bundle: New Drug Update and Pain Management.
This 15 hour bundle includes the New Drug Update by Dr. C. Wayne Weart Pharm. D., BCPS, FASHP, FAPhA , as well as a pain management/ opioids course from Dr. Gregory L. Holmquist, Pharm D., Certified Pain Educator and Oncology Pharmacist.
Course Fee: $299
2022-10-11 - Integrative Medicine and Functional Nutrition ACBN Approved Course
The American Clinical Board of Nutrition (ACBN) is a certifying agency in nutrition. This ACBN Approved Course may be used for Year A or B. It provides 12 Hours ACBN CREDIT or AMA PRA Category 2 Credit™.
- Integrative Medicine, Functional Nutrition and Detoxification (5 hours): Topic 1: What is Integrative Medicine and Interventions:, Topic 2: Functional nutrition and Herbal Therapy, Topic 3: Detoxification
- Immune and oxidative stress, Integrative Lab Analysis, Therapies for Mental Health and Sleep Management (4 hours), Topic 4: Immune and oxidative stress, Topic 5: Integrative Lab, Topic 6: Integrative Therapies for mental health and sleep management
- Systemic Thinking: Case Based Approach to Treating Difficult Conditions (3+ hours) Topic 7: Systems thinking: Treating difficult conditions; Long-COVID, resistant hypertension, diabetes and genetic cases Topic 8.: Bringing it all together: Case Studies
Course Fee: $99
2022-12-09 Opioids and Alternatives- Strategies to Optimize Success
Learning Objectives: 1. Describe how the role for the use of opioids in acute, chronic, cancer/palliative care and end-of-life pain has changed in the past decade. 2. Describe the key features of the 2022 Proposed CMS Recommendations/Guidelines for prescribing opioids for outpatients. 3. Differentiate addiction, physical dependency, and tolerance. 4. State key principles managing patients with ongoing therapy that includes opioid analgesics, including stating “red flags” for opioid misuse, abuse and diversion, and how to anticipate and manage adverse drug events. 5. Identify the main characteristics of patients who would be identified as "high risk", "moderate risk" and "low risk" for chronic opioid use. 6. State the definition of "hyperalgesia" and how to prevent/minimize this from negative- ly influencing the care of patients who are receiving opioids. 7. State three reasons why opioids may not be effective for some patients with chronic pain. 8. State key educational principles that should be applied to all patients and caregivers regarding the safe use, proper storage and disposal of opioids. 9. Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain: a) cannabinoids; b) NSAIDS; c) anti- convulsants; and, d) anti-depressants.
Credit: This program in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119
2022-04-27 Online CME Course: New Drug Update Part 1
Learning Objectives:1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts. 2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications. 3. Describe their adverse effects and drug interaction that may affect patient compliance. 4. Compare efficacy, dosage and cost to existing agent 5. Discuss the patient oriented outcomes or evi- dence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients. 6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.
Credit: This program in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119
2022-04-28 Online CME Course: New Drug Update Part 2
Learning Objectives: 1. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications. 2. Describe their adverse effects and drug interaction that may affect patient compliance. 3. Compare efficacy, dosage and cost to existing agents. 4. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients. 5. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.
Credit: This program in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119
2022-01-14: Advances in the Management of Diabetes 2022
Learning Objectives: 1. Review recent updates to the standards of care recommended by the American Diabetes Association. 2. Describe recent cardiovascular and renal outcome trials for new diabetes medications and their implications for patient care. 3. Develop a plan to safely initiate and intensify insulin therapy using guideline recommendations and patient characteristics. 4. Evaluate the use of continuous glucose monitoring (CGM) devices in the management of diabetes. 5. Optimize pharmacotherapy for a patient with diabetes using glucose data.
Credit: This recorded cme course in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119
2021-10-28 Online CME Course: Hot Topics in Ambulatory Care
Learning Objectives: 1. Describe new recommendations to recently published asthma guidelines. 2. Discuss changes in asthma medication recommendations. 3. Identify Drug therapies recommended for the management and prevention of asthma. 4. Discuss current role of traditional agents for migraine treatment and prophylaxis. 5. Discuss role of newer CGRP antagonists within migraine prophylaxis. 6. Review acute effects of COVID-19 on the primary care provider. 7. Provide guidance in managing long-term complications of COVID-19 for the primary care provider
Credit: This recorded cme course in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119
2021-10-27 Comprehensive Update in Management of Diabetes Mellitus and Obesity Including Role of Bariatric Surgery
Learning Objectives: 1. Summarize recommendations from clinical practice guidelines regarding diabetes. 2. Discuss clinical evidence and place in therapy for oral diabetes and GLP-1 agonist agents. 3.Discuss the growing evidence and role of SGLT2 inhibitors within diabetes and non-diabetes patients. 4. Analyze role of bariatric surgery in management of morbid obesity and diabetes. 5. Describe complications and medication-related changed post-bariatric surgery. 6. Evaluate and develop medication regimens post-bariatric surgery through case studies
Credit: This program in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119
2021-09-10: Online CME Course: Preventive Cardiovascular Pharmacotherapy Update
Learning Objectives: 1. Review medications and lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease. 2. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, heart failure with reduced ejection fraction, peripheral arterial disease and atrial fibrillation. 3. Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement. 4. Describe the evidence supporting bedtime dosing of antihypertensive medications. 5. Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia. 6. Define the evidence and role in therapy of non-statin medications in the treatment of hypercholesterolemia. 7. Examine results from cardiovascular outcome trials evaluating the use of angiotensin–neurolysin inhibition in heart failure with reduce ejection fraction. 8. Compare and contrast the evidence and guideline recommendations supporting the use of antiplatelet therapy for primary and secondary prevention patients. 9. Examine the evidence-based CV risk reduction benefits of medications used to treat type 2 diabetes. 10. Create treatment plans that reduce the risk of cardiovascular disease.
Credit:
Fee: $119
2021-09-08: Opioids - Maximizing Benefits, Minimizing the Risks
This course is course is valid until September 8, 2024 and may be taken for credit up to that time.
COURSE OBJECTIVES
At the conclusion of this program, the participant will be able to:
1. Describe how the role for the use of opioids in acute, chronic and cancer pain has changed in the past 20 years. 2. Differentiate addiction, physical
dependency and pseudo-addiction. 3. State the similarities and differences in the principles for the use of opioids for patients who have chronic noncancer pain and those who have end-of-life pain. 4. Identify the main characteristics of patients who would be identified as "high risk", "moderate risk" and "low risk" for chronic opioid use. 5. State the definitions of "tolerance" and "hyperalgesia" and how to prevent/minimize each of these from negatively influencing the care of patients who are receiving opioids. 6. State three reasons why opioids may not be effective for some patients with chronic pain. 7. State key educational statements that should be given to all patients and caregivers about the safe use, proper storage and disposal of opioids. 8. Describe various tamper resistant opioid products on the market and how these products may reduce misuse, abuse and diversion. 9. Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain: a) cannabinoids; b) NSAIDS; c) anticonvulsants; d) antidepressants. 10. State common side effects associated with pain medications and be able to recommend strategies to prevent the side effects from impacting the patient’s quality of life.
Fee: $119
COURSE OBJECTIVES
At the conclusion of this program, the participant will be able to:
1. Describe how the role for the use of opioids in acute, chronic and cancer pain has changed in the past 20 years. 2. Differentiate addiction, physical
dependency and pseudo-addiction. 3. State the similarities and differences in the principles for the use of opioids for patients who have chronic noncancer pain and those who have end-of-life pain. 4. Identify the main characteristics of patients who would be identified as "high risk", "moderate risk" and "low risk" for chronic opioid use. 5. State the definitions of "tolerance" and "hyperalgesia" and how to prevent/minimize each of these from negatively influencing the care of patients who are receiving opioids. 6. State three reasons why opioids may not be effective for some patients with chronic pain. 7. State key educational statements that should be given to all patients and caregivers about the safe use, proper storage and disposal of opioids. 8. Describe various tamper resistant opioid products on the market and how these products may reduce misuse, abuse and diversion. 9. Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain: a) cannabinoids; b) NSAIDS; c) anticonvulsants; d) antidepressants. 10. State common side effects associated with pain medications and be able to recommend strategies to prevent the side effects from impacting the patient’s quality of life.
Fee: $119
2021-06-09 Infectious Disease-Antibiotic Stewardship - New Antibiotics Complicated Infections-MRSA
Learning Objectives: 1. Review various newer antimicrobials that have been FDA-approved. 2. Evaluate these agents critically for use in clinical practice. 3. Discuss penicillin allergies including long-term implications. 4. Describe process and recent data supporting intervention strategies to de-label patients. 5. Describe disease states for which shorter durations of therapy data are growing. 6. Review data for which IV to PO conversion is growing for complicated infections
Credit: This recorded cme course in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Fee: $119